Research And Development Expense Reversal Excluding Acquired In Process Cost

Name: AnaptysBio, Inc. Research And Development Expense Reversal Excluding Acquired In Process Cost by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

AnaptysBio, Inc.·Business Segments·2 segments

Breakdown

Segment	Q1 '26
Biopharma Company	$33.96M
Royalty Management Company	$36K
Total	$33.96M

Segments

Biopharma CompanyView metric

Royalty Management CompanyView metric